National Cholesterol Education Program Adult Treatment Panel-III guidelines and the abolition of symptomatic coronary artery disease

American Journal of Cardiology

Volumn 91, Issue 5, 2003, Pages 654-

  Silverstein, H Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CHOLESTEROL; CYTOKINE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INTERLEUKIN 6; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MATRIX METALLOPROTEINASE;

AGE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; MEDICAL EDUCATION; NOTE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE;

EID: 0037374341     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03294-0     Document Type: Note

References (7)

1. Ansell B.J., Waters D.D. Reassessment of National Cholesterol Education Program Adult Treatment Panel-III guidelines one year later . Am J Cardiol. 90:2002;524-525.
2. Castelli W.P. The new pathophysiology of coronary artery disease. Am J Cardiol. 82:1998;60T-65T.
3. Roberts W. Getting more people on statins. Am J Cardiol. 90:2002;683-685.
4. Ornish D., Scherwitz L.W., Billings J.H., Gould K.L., Merritt T.A., Sparler S., Armstrong W.T., Ports T.A., Kirkeeido R.L., Hogeboom C., Brand R.J. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 280:1998;2001-2007.
5. Esselstyn C.B. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology). Am J Cardiol. 84:1999;339-341.
6. Silverstein H.R. Preventing heart disease. Lancet. 335:1990;227.
7. Silverstein H.R. Coronary artery disease virtually preventable. Med World News. 34:1994;17.